In the United States, more than 94 million individuals have actually had both Pfizer-BioNTech vaccines compared to 65 million who have actually had both Moderna shots, according to the Centers for Disease Control and Prevention.
The research study compared the antibody levels of close to 1,600 Belgian health workers, of whom 688 were immunized with Moderna and 959 had Pfizer-BioNTech.
A study discovered that Modernas vaccine produced twice as numerous antibodies as the Pfizer-BioNTech vaccine.REUTERS/ Dado Ruvic/Illustration/File Photo
The results revealed Modernas vaccine created twice as many antibodies as the Pfizer-BioNTech vaccine.
” I would advise care in making the conclusion that due to the fact that Moderna showed a slightly higher peak usually that its efficacy will be slower to wane,” Emory University biostatistician David Benkeser told Bloomberg.
Antibody levels after the 2nd dosage of the two most popular vaccines in the US were higher in people who had the Moderna shot, according to new research published in the Journal of the American Medical Association.
The second vaccine of Moderna is typically given four weeks after the very first shot, while the second Pfizer vaccine is administered three weeks following the very first shot.
The researchers said the difference might simply be that the 2nd Moderna vaccine is, on average, administered one week behind the Pfizer vaccine.
Modernas vaccine produces two times as numerous antibodies as the Pfizer-BioNTech vaccine, brand-new research has exposed.
Research studies have actually shown even fairly low levels of antibodies are protective.
” Such a conclusion requires a host of assumptions that have actually not yet been examined.”.
But researchers still do not know whether having more antibodies means someone is any less likely to contract or spread out the infection.